as on January 16, 2026 at 4:01 pm IST
Day's Low
Day's High
2.09%
Downside
2.06%
Upside
52 Week's Low
52 Week's High
5.49%
Downside
53.66%
Upside
as on January 16, 2026 at 4:01 pm IST
Market Cap
₹3,170.43 Cr
Return on Equity (ROE)
12.33
PE Ratio (TTM)
55.66
Return on capital employed (ROCE)
12.88
Industry PE ratio
41.53
Beta (LTM)
1.08
P/B Ratio
5.61
Dividend Yield
0.03
PEG Ratio
-19.88
Quarterly Earnings Growth YOY
-22.74
EPS (TTM)
6.95
Sector
Pharmaceuticals
Book Value
59.93
Technical Analysis
Bearish
View Technical Analysis
as on January 16, 2026 at 4:01 pm IST
Gufic BioSciences in the last 5 years
Lowest (0.00x)
March 28, 2024
Industry (41.53x)
January 16, 2026
Today (55.66x)
January 16, 2026
Highest (65.57x)
July 30, 2025
Today’s Price to Earnings Ratio: 55.66x
Compare market cap, revenue, PE, and other key metrics of Gufic BioSciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 3,170.43 | 32.28% | 0.69 | 69 | 819 | |
| NA | 168.18 | 3.59% | 0.00 | 5 | 97 | |
| NA | 20,660.00 | 21.05% | 0.00 | 115 | 1,716 | |
| NA | 3,815.88 | 107.73% | 0.00 | 183 | 653 | |
| NA | 455.95 | 15.54% | 0.00 | NA | NA |
Get share price movements and forecasts by analysts on Gufic BioSciences.
Source: S&P Global Market Intelligence
Search interest for Gufic BioSciences Ltd Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Gufic BioSciences.
Gufic BioSciences Ltd’s net profit fell -22.74% since last year same period to ₹16.82Cr in the Q2 2025-2026. On a quarterly growth basis, Gufic BioSciences Ltd has generated 28.69% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Gufic BioSciences Ltd has declared dividend of ₹0.10 per share on 30 May 2025 - translating a dividend yield of 0.03%.
Read More about DividendsCheck stock indices that include Gufic BioSciences.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.32% to 0.34% in Sep 2025 quarter
MF Holding Up
![]()
Mutual Funds have increased holdings from 3.38% to 3.48% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.0% return, outperforming this stock by 58.0%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.0% return, outperforming this stock by 114.6%
Promoter Holding Down
![]()
Promoters have decreased holdings from 72.51% to 72.50% in Sep 2025 quarter
Price Dip
![]()
In the last 1 month, GUFICBIO stock has moved down by -10.4%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 23.80% to 23.51% in Sep 2025 quarter
| Organisation | Gufic BioSciences Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Jayesh P Choksi |
| E-voting on shares | Click here to vote |
Gufic BioSciences share price today stands at ₹316.15 as on at the close of the market. Gufic BioSciences share today touched a day high of ₹322.65 and a low of ₹309.55.
Gufic BioSciences touched a 52 week high of ₹485.8 and a 52 week low of ₹298.8. Gufic BioSciences share price today i.e. is closed at ₹316.15, which is -34.92% down from its 52 week high and 5.81% up from its 52 week low.
Gufic BioSciences market capitalisation is ₹3,170.43 Cr as on .
To buy Gufic BioSciences shares, you need to follow these steps:
Gufic BioSciences trading volume is 31.70K as on . This means that 31.70K shares of Gufic BioSciences were bought and sold on the stock market during today's trading session.